Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English | Polski
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Guetter S"" wg kryterium: Autor

  Lista filtrów

Ogranicz do:

Wyrównaj
    Wyświetlanie 1-7 z 7
    Podgląd okładki
    Tytuł :
    Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
    Autorzy :
    Werner-Klein M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. .
    Grujovic A; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Telexos GmbH, Weilheim, Germany.
    Irlbeck C; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Obradović M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.; Wellmera AG, Basel, Switzerland.
    Hoffmann M; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Koerkel-Qu H; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Lu X; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Treitschke S; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Köstler C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Botteron C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Weidele K; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Werno C; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Polzer B; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Kirsch S; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Gužvić M; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Warfsmann J; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Honarnejad K; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Czyz Z; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Feliciello G; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
    Blochberger I; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Grunewald S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Schneider E; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Haunschild G; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Patwary N; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Guetter S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Huber S; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
    Rack B; Department OB&GYN and CCCLMU, Breast Center, LMU University Hospital, 80337, Munich, Germany.; Department of Gynecology, Ulm University Hospital, Ulm, Germany.
    Harbeck N; Department OB&GYN and CCCLMU, Breast Center, LMU University Hospital, 80337, Munich, Germany.
    Buchholz S; Clinic of Gynecology and Obstetrics, University Medical Center Regensburg, 93053, Regensburg, Germany.
    Rümmele P; Department of Pathology, University of Regensburg, 93053, Regensburg, Germany.; Institute of Pathology, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
    Heine N; University Center of Plastic-, Aesthetic, Hand- and Reconstructive Surgery, University of Regensburg, Regensburg, Germany.
    Rose-John S; Institute of Biochemistry, Christian-Albrechts-Universität Kiel, Kiel, Germany.
    Klein CA; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. .; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany. .
    Pokaż więcej
    Źródło :
    Nature communications [Nat Commun] 2020 Oct 05; Vol. 11 (1), pp. 4977. Date of Electronic Publication: 2020 Oct 05.
    Typ publikacji :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Signal Transduction*
    Interleukin-6/*metabolism
    Neoplastic Stem Cells/*metabolism
    Neoplastic Stem Cells/*pathology
    Bone Marrow/pathology ; Breast/cytology ; Breast Neoplasms/pathology ; Class I Phosphatidylinositol 3-Kinases/genetics ; Class I Phosphatidylinositol 3-Kinases/metabolism ; Cytokine Receptor gp130/metabolism ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Female ; Humans ; Interleukin-6/genetics ; Mutation ; Neoplasm Metastasis/genetics ; Receptors, Interleukin-6/deficiency ; Receptors, Interleukin-6/metabolism ; Stromal Cells/metabolism ; Tumor Microenvironment
    Czasopismo naukowe
    Szczegóły
    Podgląd okładki
    Tytuł :
    The Drosophila fussel gene is required for bitter gustatory neuron differentiation acting within an Rpd3 dependent chromatin modifying complex.
    Autorzy :
    Rass M; Department of Developmental Biology, Institute of Zoology, University of Regensburg, Regensburg, Bavaria, Germany.
    Oestreich S; Department of Developmental Biology, Institute of Zoology, University of Regensburg, Regensburg, Bavaria, Germany.
    Guetter S; Department of Developmental Biology, Institute of Zoology, University of Regensburg, Regensburg, Bavaria, Germany.
    Fischer S; Department of Developmental Biology, Institute of Zoology, University of Regensburg, Regensburg, Bavaria, Germany.
    Schneuwly S; Department of Developmental Biology, Institute of Zoology, University of Regensburg, Regensburg, Bavaria, Germany.
    Pokaż więcej
    Źródło :
    PLoS genetics [PLoS Genet] 2019 Feb 07; Vol. 15 (2), pp. e1007940. Date of Electronic Publication: 2019 Feb 07 (Print Publication: 2019).
    Typ publikacji :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Drosophila Proteins/*genetics
    Drosophila melanogaster/*genetics
    Histone Deacetylase 1/*genetics
    Nerve Tissue Proteins/*genetics
    Proto-Oncogene Proteins/*genetics
    Receptors, Cell Surface/*genetics
    Animals ; Animals, Genetically Modified ; Bone Morphogenetic Proteins/metabolism ; Cell Differentiation ; Chromatin/genetics ; Chromatin/metabolism ; Drosophila Proteins/metabolism ; Drosophila melanogaster/growth & development ; Drosophila melanogaster/metabolism ; Female ; Genes, Insect ; Histone Deacetylase 1/metabolism ; Male ; Mutation ; Nerve Tissue Proteins/metabolism ; Neurons/cytology ; Neurons/metabolism ; Proto-Oncogene Proteins/metabolism ; Receptors, Cell Surface/metabolism ; Sensory Receptor Cells/cytology ; Sensory Receptor Cells/metabolism ; Signal Transduction ; Taste/genetics
    Czasopismo naukowe
    Szczegóły Pełny tekst Pełny tekst
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies